The Safety Rates Drug Report

Member Login
2004.Q1    2004.Q2    2004.Q3    2004.Q4    2005.Q1    2005.Q2    2005.Q3    2005.Q4    2006.Q1    2006.Q2    2006.Q3    2006.Q4    2007.Q1    2007.Q2    2007.Q3    2007.Q4    2008.Q1    2008.Q2    2008.Q3    2008.Q4    2009.Q1    2009.Q2    2009.Q3    2009.Q4    2010.Q1    2010.Q2    2010.Q3    2010.Q4    2011.Q1    2011.Q2    2011.Q3    2011.Q4    2012.Q1    2012.Q2    2012.Q3    2012.Q4    2013.Q1    2013.Q2    2013.Q3    2013.Q4    2014.Q1    2014.Q2    2014.Q3    2014.Q4    2015.Q1    2015.Q2    2015.Q3    2015.Q4    2016.Q1    2016.Q2    2016.Q3   

Drug     Injury     Quarter    

Person who experienced the adverse event (patient)

Event ID CASEID CASEVERSION I F COD EVENT DT MFR DT INIT FDA DT FDA DT REPT COD AUTH NUM MFR NUM MFR SNDR LIT REF AGE AGE COD AGE GRP GNDR COD E SUB WT WT COD REPT DT TO MFR OCCP COD REPORTER COUNTRY OCCR COUNTRY
126965841 12696584 1 I 20160802 20160802 20160830 20160830 EXP NO-PFIZER INC-2016373211 PFIZER 55.00 YR M Y 0.00000 20160830 OT NO NO

Drug(s) used by person

Event ID CASEID DRUG SEQ ROLE COD DRUGNAME PROD AI VAL VBM ROUTE DOSE VBM CUM DOSE CHR CUM DOSE UNIT DECHAL RECHAL LOT NUM EXP DT NDA NUM DOSE AMT DOSE UNIT DOSE FORM DOSE FREQ
126965841 12696584 1 SS FLUOROBLASTIN FLUOROURACIL 1 Intravenous (not otherwise specified) 900 MG 0 900 MG
126965841 12696584 2 SS FLUOROBLASTIN FLUOROURACIL 1 Intravenous (not otherwise specified) 900 MG 0 900 MG
126965841 12696584 3 SS FLUOROBLASTIN FLUOROURACIL 1 900 MG 0 900 MG
126965841 12696584 4 PS OXALIPLATIN. OXALIPLATIN 1 Intravenous (not otherwise specified) 153 MG Y 78813 153 MG
126965841 12696584 5 SS OXALIPLATIN. OXALIPLATIN 1 Intravenous (not otherwise specified) 153 MG Y 78813 153 MG
126965841 12696584 6 SS OXALIPLATIN. OXALIPLATIN 1 Intravenous (not otherwise specified) 153 MG Y 78813 153 MG
126965841 12696584 7 SS CALCIUM FOLINATE LEUCOVORIN CALCIUM 1 Intravenous (not otherwise specified) 100 MG U 8107 100 MG
126965841 12696584 8 SS CALCIUM FOLINATE LEUCOVORIN CALCIUM 1 Intravenous (not otherwise specified) 100 MG U 8107 100 MG
126965841 12696584 9 SS CALCIUM FOLINATE LEUCOVORIN CALCIUM 1 Intravenous (not otherwise specified) 100 MG U 8107 100 MG
126965841 12696584 10 C KLEXANE ENOXAPARIN 1 Subcutaneous 60 MG 0 60 MG
126965841 12696584 11 C ONDANSETRON ONDANSETRON 1 8 MG 0 8 MG
126965841 12696584 12 C EMEND APREPITANT 1 125 MG 0 125 MG
126965841 12696584 13 C DEXAMETHASONE. DEXAMETHASONE 1 Oral 16 MG 0 16 MG

Indications of drugs used

Event ID CASEID INDI DRUG SEQ INDI PT
126965841 12696584 1 Rectal cancer
126965841 12696584 4 Rectal cancer
126965841 12696584 7 Rectal cancer
126965841 12696584 10 Deep vein thrombosis
126965841 12696584 11 Premedication
126965841 12696584 12 Prophylaxis of nausea and vomiting
126965841 12696584 13 Premedication

Outcome of event

Event ID CASEID OUTC COD
126965841 12696584 OT
126965841 12696584 HO

Reactions reported

Event ID CASEID DRUG REC ACT PT
126965841 12696584 Abdominal pain upper
126965841 12696584 Cold sweat
126965841 12696584 Nausea
126965841 12696584 Restlessness

Reporting Sources (this data is often not reported and may therefore be missing here)

no results found

Therapies reported

Event ID CASEID DSG DRUG SEQ START DT END DT DUR DUR COD
126965841 12696584 1 20160704 0
126965841 12696584 2 20160705 0
126965841 12696584 3 20160802 0
126965841 12696584 4 20160704 0
126965841 12696584 5 20160705 0
126965841 12696584 6 20160802 0
126965841 12696584 7 20160704 0
126965841 12696584 8 20160705 0
126965841 12696584 9 20160802 0